Companies that own Alkermes PLC
PRIMECAP Management Co.
23,336,493
15.03%
44,160
0.71%
06/30/2018
Fidelity Management & Research Co.
23,156,390
14.91%
-158,948
0.11%
06/30/2018
Wellington Management Co. LLP
21,596,098
13.91%
516,398
0.18%
06/30/2018
T. Rowe Price Associates, Inc.
18,749,378
12.07%
1,787,554
0.12%
06/30/2018
The Vanguard Group, Inc.
12,888,617
8.3%
-74,903
0.02%
06/30/2018
BlackRock Fund Advisors
7,928,508
5.11%
-137,468
0.02%
06/30/2018
Woodford Investment Management Ltd.
4,717,010
3.04%
-553,418
1.46%
06/30/2018
Invesco Asset Management Ltd.
4,163,083
2.68%
0
0.23%
06/30/2018
SSgA Funds Management, Inc.
4,118,056
2.65%
86,914
0.01%
06/30/2018
Franklin Templeton Institutional LLC
3,181,900
2.04%
858,770
2.47%
06/30/2018
| Address |
Connaught House
Dublin Dublin D04 C5Y6
Ireland
|
|
Employees
|
- |
| Website |
http://www.alkermes.com |
| Updated |
07/08/2019 |
| Alkermes Plc IS a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. It operates through the following geographical segments: U. S. |
